In terms of T2DM treatment, 51.50% of individuals were using metformin only, 10.48% were on insulin only, 36.53% were using both metformin and insulin, and 1.49% were not on any pharmacologic therapy (relying on diet and exercise due to metformin intolerance). This evidence concerns the gene INS and type 2 diabetes mellitus.